3.49

0.85% -0.03

After Hours: 3.49

Neuronetics Inc (STIM)

Overview News Price History Option Chain Discussions Forecast

Neuronetics Inc stock is currently priced at $3.49, with a 24-hour trading volume of 44,573. It has seen a -0.85% decreased in the last 24 hours and a -26.68% declined in the past month. The chart indicates a potential bearish trend, as the stock is below the $3.55 pivot point. If it approaches the $3.42 support level, significant changes may occur.

Previous Close:

$3.52

Open:

$3.52

24h Volume:

44,573

Market Cap:

$104.61M

Revenue:

$69.23M

Net Income/Loss:

$-33.10M

P/E Ratio:

-3.0885

EPS:

-1.13

Net Cash Flow:

$-39.26M

1W Performance:

-8.16%

1M Performance:

-26.68%

6M Performance:

+232.38%

1Y Performance:

+56.50%

1D Range:

$3.345

$3.55

52W Range:

$1.03

$5.0699

Neuronetics Inc Stock (STIM) Company Profile

Name

Neuronetics Inc

Sector

Healthcare (1191)

Industry

Diagnostics & Research (66)

Phone

610-640-4202

Address

3222 Phoenixville Pike, Malvern, PA

Employee

145

Twitter

@tmstherapy

Next Earnings Date

2024-05-07

Latest SEC Filings

STIM's Discussions on Twitter

Neuronetics Inc Stock (STIM) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Oct-13-21	Downgrade	BTIG Research	Buy → Neutral
Oct-13-21	Downgrade	William Blair	Outperform → Mkt Perform
Jan-22-21	Upgrade	William Blair	Mkt Perform → Outperform
Feb-06-20	Initiated	BTIG Research	Buy
Jul-24-18	Initiated	Canaccord Genuity	Buy

Neuronetics Inc Stock (STIM) Latest News

Neuronetics to Report First Quarter 2024 Financial and Operating Results and Host Conference Call

GlobeNewswire Inc.

New Publication in Brain Stimulation Confirms Full TMS Treatment Course Is Vital

GlobeNewswire Inc.

Why Landos Biopharma Shares Are Trading Higher By Over 170%? Here Are Other Stocks Moving In Monday's Mid-Day Session

Benzinga

Neuronetics Inc Stock (STIM) Financials Data

Neuronetics Inc (STIM) Revenue 2024

STIM reported a revenue (TTM) of $69.23 million for the quarter ending September 30, 2023, a +11.61% rise year-over-year.

Neuronetics Inc (STIM) Net Income 2024

STIM net income (TTM) was -$33.10 million for the quarter ending September 30, 2023, a +9.32% increase year-over-year.

Neuronetics Inc (STIM) Cash Flow 2024

STIM recorded a free cash flow (TTM) of -$39.26 million for the quarter ending September 30, 2023, a -9.89% decrease year-over-year.

Neuronetics Inc (STIM) Earnings per Share 2024

STIM earnings per share (TTM) was -$1.18 for the quarter ending September 30, 2023, a +13.87% growth year-over-year.

Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with psychiatric disorders. It offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment for adult patients with major depressive disorder. The company's NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed MRI-strength magnetic field, which induces electrical currents designed to stimulate specific areas of the brain associated with mood. Neuronetics, Inc. was incorporated in 2003 and is headquartered in Malvern, Pennsylvania.